Implandata Ophthalmic Products
Empowering People to Take Control of Glaucoma…, Anytime and Anywhere.
Launch date
Employees
Market cap
-
Enterprise valuation
€12—18m (Dealroom.co estimates Oct 2014.)
Company register number HRB 205386 (Hannover)
Hanover Lower Saxony (HQ)
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | - | <1m | <1m | <1m | <1m | <1m | - |
% growth | - | - | 14 % | 505 % | (76 %) | 74 % | - |
EBITDA | - | (1.2m) | (1.7m) | (2.1m) | (1.7m) | (1.3m) | - |
% EBITDA margin | - | (2669 %) | (3301 %) | (678 %) | (2317 %) | (1007 %) | - |
Profit | (1.9m) | (1.2m) | (1.7m) | (2.1m) | (<1m) | (1.4m) | (1.6m) |
% profit margin | - | (2717 %) | (3323 %) | (689 %) | (922 %) | (1094 %) | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€700k | Seed | ||
N/A | €1.4m | Series A | |
N/A | €1.6m | Series A | |
N/A | €3.0m | Series B | |
* | N/A | Series C | |
Total Funding | €6.7m |
Related Content
Recent News about Implandata Ophthalmic Products
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.